Biocon Limited Biocon Limited

Biocon Limited

BIOCON

Clasificación en acciones #3387
Biocon Limited functions as a biopharmaceutical firm, engaged in the production... Biocon Limited functions as a biopharmaceutical firm, engaged in the production of pharmaceutical, medicinal chemical, and plant-derived products. Its business activities are organized into distinct segments: Generics, Novel Biologics, Biosimilars, and Research Services. The company dedicates its efforts to crucial therapeutic domains, including diabetes, oncology, immunology, ophthalmology, and bone health disorders. Furthermore, Biocon provides comprehensive services encompassing the discovery, development, and manufacturing of both small and large molecules. With a wide international presence, it caters to customers in roughly 120 nations. Headquartered in Bengaluru, India, Biocon Limited commenced operations in 1978.
Precio por acción
$3.75
Última sincronización: 2026-10-19
Capitalización bursátil
$5.13B
Cambio (1 día)
-2.30%
Cambio (1 año)
-9.49%
País
IN
Comercio Biocon Limited (BIOCON)

Categoría

Healthcare
Ratio P/S de Biocon Limited (BIOCON)
Ratio P/S al October 2026 TTM: 2.80
Según los informes financieros más recientes y el precio de las acciones de Biocon Limited, el ratio P/S actual (TTM) es 2.80. Al final de 2024, el ratio P/S era 2.19.
Historial del ratio P/S de Biocon Limited desde 2004 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
2026 (TTM) 2.80 5.35%
2025 2.66 21.75%
2024 2.19 -0.79%
2023 2.20 -54.89%
2022 4.88 -28.13%
2021 6.80 33.65%
2020 5.08 -23.50%
2019 6.65 -22.37%
2018 8.56 49.90%
2017 5.71 101.52%
2016 2.83 -6.69%
2015 3.04 12.72%
2014 2.70 18.90%
2013 2.27 -0.79%
2012 2.28 -22.10%
2011 2.93 7.96%
2010 2.72 34.93%
2009 2.01 -59.64%
2008 4.99 -12.65%
2007 5.71 -7.76%
2006 6.19 3.79%
2005 5.97 -26.97%
2004 8.17 0.00%
Ratio P/S de empresas similares o competidoras
Empresa Ratio P/S Diferencia del ratio P/S País
10.02 257.64%
US
40.55 1,347.05%
US
3.96 41.35%
AU
- -
CH
10.15 262.07%
NL